Neurocrine Biosciences Inc. (NBIX) Financials Nov 14, 2014, 4:28 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Neurocrine Biosciences Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.95M 33.5M 77.41M 53.14M 2.92M
Cost of Goods Sold (COGS) incl. D&A 3.18M 1.44M 694,000 - 671,000
COGS excluding D&A 0 0 0 - 0
Depreciation & Amortization Expense 3.18M 1.44M 694,000 657,000 671,000
Depreciation 3.18M 1.44M 694,000 657,000 671,000
Amortization of Intangibles 0 0 0 0 0
Gross Income (226,000) 32.07M 76.72M - 2.25M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 44.86M 42.99M 41.72M 49.94M 51.93M
Research & Development 33.71M 31.15M 30.95M 37.16M 39.25M
Other SG&A 11.15M 11.84M 10.76M 12.78M 12.68M
Other Operating Expense 0 0 0 1.09M 0
Unusual Expense 8.58M 2.8M 1.08M 0 -
EBIT after Unusual Expense (8.58M) (2.8M) (1.08M) 0 -
Non Operating Income/Expense 1.94M 5.36M 3.21M 3.09M 3.19M
Non-Operating Interest Income 691,000 397,000 435,000 489,000 400,000
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense - 0 0 0 0
Gross Interest Expense - 0 0 0 0
Interest Capitalized 0 0 0 0 0
Pretax Income (51.04M) (7.97M) 37.57M 5.03M (46.09M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (51.04M) (7.97M) 37.57M 5.03M (46.09M)
Minority Interest Expense 0 0 0 0 0
Net Income (51.04M) (7.97M) 37.57M 5.03M (46.09M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (51.04M) (7.97M) 37.57M 5.03M (46.09M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (51.04M) (7.97M) 37.57M 5.03M (46.09M)
EPS (Basic) (1.30) (0.15) 0.68 0.08 (0.69)
Basic Shares Outstanding 39.14M 52.82M 55.18M 65.62M 66.99M
EPS (Diluted) (1.30) (0.15) 0.67 0.08 (0.69)
Diluted Shares Outstanding 39.14M 52.82M 56.35M 66.95M 66.99M
EBITDA (41.91M) (9.49M) 35.7M 2.11M (49.01M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Neurocrine Biosciences Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.95M 33.5M 77.41M 53.14M 2.92M
Cost of Goods Sold (COGS) incl. D&A 3.18M 1.44M 694,000 - 671,000
COGS excluding D&A 0 0 0 - 0
Depreciation & Amortization Expense 3.18M 1.44M 694,000 657,000 671,000
Depreciation 3.18M 1.44M 694,000 657,000 671,000
Amortization of Intangibles 0 0 0 0 0
Gross Income (226,000) 32.07M 76.72M - 2.25M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 44.86M 42.99M 41.72M 49.94M 51.93M
Research & Development 33.71M 31.15M 30.95M 37.16M 39.25M
Other SG&A 11.15M 11.84M 10.76M 12.78M 12.68M
Other Operating Expense 0 0 0 1.09M 0
Unusual Expense 8.58M 2.8M 1.08M 0 -
EBIT after Unusual Expense (8.58M) (2.8M) (1.08M) 0 -
Non Operating Income/Expense 1.94M 5.36M 3.21M 3.09M 3.19M
Non-Operating Interest Income 691,000 397,000 435,000 489,000 400,000
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense - 0 0 0 0
Gross Interest Expense - 0 0 0 0
Interest Capitalized 0 0 0 0 0
Pretax Income (51.04M) (7.97M) 37.57M 5.03M (46.09M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (51.04M) (7.97M) 37.57M 5.03M (46.09M)
Minority Interest Expense 0 0 0 0 0
Net Income (51.04M) (7.97M) 37.57M 5.03M (46.09M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (51.04M) (7.97M) 37.57M 5.03M (46.09M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (51.04M) (7.97M) 37.57M 5.03M (46.09M)
EPS (Basic) (1.30) (0.15) 0.68 0.08 (0.69)
Basic Shares Outstanding 39.14M 52.82M 55.18M 65.62M 66.99M
EPS (Diluted) (1.30) (0.15) 0.67 0.08 (0.69)
Diluted Shares Outstanding 39.14M 52.82M 56.35M 66.95M 66.99M
EBITDA (41.91M) (9.49M) 35.7M 2.11M (49.01M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
